Valeant Of Canada Agrees To Buy Russia’s Natur Produkt For $180 Million
This article was originally published in PharmAsia News
Executive Summary
Canada’s Valeant Pharmaceuticals International has reached an agreement to buy Russia’s Natur Produkt International for $180 million to give Valeant entrée into the nation’s over-the-counter market.